FindTrial
Sign In

Effect of Rasayana Vati and Shatavari Taila Matra Basti on Ovarian Follicular Development in Women

Integrative Approach of Rasayana Vati and Shatavari Taila Matra Basti on Enhancing Ovarian Follicular Development in Women - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110175
Enrollment
30
Registered
2026-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

Chandra Shekhar Singh Ayurved Chikitsalaya evam Shodh Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with low ovarian reserve. Anovulatory cycles. Primary Infertility. Married Female unable to conceive. Consent to participate.

Exclusion criteria

Exclusion criteria: Women with systemic illness like cancer, surgical infertility, endometriosis, ovarian tumors etc. Women on hormonal or IVF treatment during study period unwilling to consent. Patient in which matra basti is contraindicated. Known allergy to any study ingredients

Design outcomes

Primary

MeasureTime frame
Change in ovarian follicular development assessed by transvaginal ultrasonography (TVS) in terms of follicular size (mm) and number of dominant follicles from baseline to end of treatment (after 2 3 menstrual cycles).Timepoint: 18 Months—

Secondary

MeasureTime frame
Ovulation rate, endometrial thickness, hormonal profile (FSH, LH, E2, Progesterone), menstrual regularity, and conception rate.Timepoint: 550 Days—

Countries

India

Contacts

Public ContactDr Prerna Pandey

Chandra Shekhar Singh Ayurvedic Sansthan

shefalishah00007@gmail.com8400776677

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026